Form 4: LifeStance Health Group CEO Reports Stock Transaction
Insider Transaction (Form 4)
David Bourdon, Chief Executive Officer and a Director of LifeStance Health Group, Inc., reported a transaction in 150,000 shares of common stock on September 2, 2026.
Summary
- Other acquisition/disposition: disposed of 150,000 Common Stock on September 2, 2026; holds 1,248,247 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David Bourdon — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Other acquisition/disposition | Common Stock | 150,000 | — | — | 1,248,247 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Other acquisition/disposition (150,000 shares) |
Keywords
insider transaction, Form 4, LFST, LifeStance Health Group, Inc., neutral, David Bourdon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.